Norris Perne & French’s Merck MRK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $22.4M | Buy |
174,343
+491
| +0.3% | +$57.5K | 1.31% | 18 |
|
|
2026
Q1 | $20.9M | Sell |
173,852
-78,310
| -31% | -$9.04M | 1.4% | 15 |
|
|
2025
Q4 | $26.5M | Buy |
252,162
+28,635
| +13% | +$2.69M | 1.75% | 20 |
|
|
2025
Q3 | $18.8M | Sell |
223,527
-36,819
| -14% | -$3.03M | 1.3% | 28 |
|
|
2025
Q2 | $20.6M | Buy |
260,346
+2,295
| +0.9% | +$182K | 1.44% | 27 |
|
|
2025
Q1 | $23.2M | Buy |
258,051
+2,255
| +0.9% | +$211K | 1.74% | 20 |
|
|
2024
Q4 | $25.4M | Buy |
255,796
+909
| +0.4% | +$93.7K | 1.83% | 19 |
|
|
2024
Q3 | $28.9M | Buy |
254,887
+51,858
| +26% | +$6.16M | 1.98% | 14 |
|
|
2024
Q2 | $25.1M | Sell |
203,029
-687
| -0.3% | -$88.5K | 1.82% | 14 |
|
|
2024
Q1 | $26.9M | Buy |
203,716
+548
| +0.3% | +$67.5K | 1.93% | 15 |
|
|
2023
Q4 | $22.1M | Buy |
203,168
+29,452
| +17% | +$3.06M | 1.71% | 19 |
|
|
2023
Q3 | $17.9M | Buy |
173,716
+1,848
| +1% | +$199K | 1.56% | 22 |
|
|
2023
Q2 | $19.8M | Buy |
171,868
+1,340
| +0.8% | +$152K | 1.67% | 20 |
|
|
2023
Q1 | $18.2M | Sell |
170,528
-1,275
| -0.7% | -$138K | 1.66% | 25 |
|
|
2022
Q4 | $19.1M | Buy |
171,803
+455
| +0.3% | +$46.5K | 1.88% | 14 |
|
|
2022
Q3 | $14.8M | Sell |
171,348
-70,408
| -29% | -$6.29M | 1.53% | 26 |
|
|
2022
Q2 | $22M | Sell |
241,756
-195
| -0.1% | -$17.3K | 2.12% | 9 |
|
|
2022
Q1 | $19.9M | Sell |
241,951
-1,567
| -0.6% | -$124K | 1.6% | 21 |
|
|
2021
Q4 | $18.7M | Sell |
243,518
-80,957
| -25% | -$6.45M | 1.45% | 28 |
|
|
2021
Q3 | $24.4M | Buy |
324,475
+8,770
| +3% | +$667K | 2.09% | 9 |
|
|
2021
Q2 | $24.6M | Buy |
315,705
+35,016
| +12% | +$2.6M | 2.12% | 10 |
|
|
2021
Q1 | $20.6M | Sell |
280,689
-5,192
| -2% | -$383K | 1.91% | 15 |
|
|
2020
Q4 | $22.3M | Buy |
285,881
+27,194
| +11% | +$2.08M | 2.1% | 13 |
|
|
2020
Q3 | $20.5M | Buy |
258,687
+50,007
| +24% | +$3.92M | 2.22% | 12 |
|
|
2020
Q2 | $15.4M | Buy |
208,680
+7,972
| +4% | +$600K | 1.87% | 20 |
|
|
2020
Q1 | $14.7M | Buy |
200,708
+33,076
| +20% | +$2.6M | 2.21% | 12 |
|
|
2019
Q4 | $14.5M | Buy |
167,632
+149
| +0.1% | +$12.2K | 1.74% | 19 |
|
|
2019
Q3 | $13.5M | Buy |
167,483
+182
| +0.1% | +$14.6K | 1.68% | 19 |
|
|
2019
Q2 | $13.4M | Buy |
167,301
+159
| +0.1% | +$12.2K | 1.69% | 21 |
|
|
2019
Q1 | $13.3M | Buy |
167,142
+4,954
| +3% | +$371K | 1.75% | 20 |
|
|
2018
Q4 | $11.8M | Buy |
162,188
+1,809
| +1% | +$128K | 1.85% | 16 |
|
|
2018
Q3 | $10.9M | Buy |
160,379
+10,030
| +7% | +$639K | 1.42% | 30 |
|
|
2018
Q2 | $8.71M | Buy |
150,349
+7,894
| +6% | +$445K | 1.27% | 36 |
|
|
2018
Q1 | $7.4M | Sell |
142,455
-524
| -0.4% | -$28.3K | 1.08% | 43 |
|
|
2017
Q4 | $7.68M | Sell |
142,979
-2,654
| -2% | -$147K | 1.12% | 42 |
|
|
2017
Q3 | $8.9M | Buy |
145,633
+3,709
| +3% | +$225K | 1.39% | 26 |
|
|
2017
Q2 | $8.68M | Buy |
141,924
+5,387
| +4% | +$328K | 1.46% | 24 |
|
|
2017
Q1 | $8.28M | Buy |
136,537
+1,047
| +0.8% | +$63.5K | 1.55% | 17 |
|
|
2016
Q4 | $7.61M | Buy |
135,490
+3,519
| +3% | +$206K | 1.5% | 19 |
|
|
2016
Q3 | $7.86M | Buy |
131,971
+3,240
| +3% | +$189K | 1.64% | 20 |
|
|
2016
Q2 | $7.08M | Sell |
128,731
-5,653
| -4% | -$301K | 1.53% | 23 |
|
|
2016
Q1 | $6.79M | Buy |
134,384
+2,850
| +2% | +$140K | 1.41% | 25 |
|
|
2015
Q4 | $6.63M | Buy |
131,534
+21,211
| +19% | +$1.07M | 1.39% | 26 |
|
|
2015
Q3 | $5.2M | Buy |
110,323
+30,084
| +37% | +$1.6M | 1.24% | 30 |
|
|
2015
Q2 | $4.36M | Buy |
80,239
+3,487
| +5% | +$196K | 0.83% | 45 |
|
|
2015
Q1 | $4.21M | Buy |
76,752
+1,411
| +2% | +$79.9K | 0.78% | 45 |
|
|
2014
Q4 | $4.08M | Buy |
75,341
+3,897
| +5% | +$217K | 0.75% | 47 |
|
|
2014
Q3 | $4.04M | Buy |
71,444
+427
| +0.6% | +$24K | 0.78% | 46 |
|
|
2014
Q2 | $3.92M | Buy |
71,017
+949
| +1% | +$51.8K | 0.74% | 48 |
|
|
2014
Q1 | $3.8M | Buy |
70,068
+1,271
| +2% | +$65.8K | 0.74% | 47 |
|
|
2013
Q4 | $3.29M | Buy |
68,797
+3,041
| +5% | +$139K | 0.62% | 50 |
|
|
2013
Q3 | $2.99M | Buy |
65,756
+2,670
| +4% | +$122K | 0.62% | 52 |
|
|
2013
Q2 | $2.8M | Buy |
+63,086
| New | +$2.82M | 0.6% | 52 |
|
Other funds holding MRK
ATO
Norris Perne & French's MRK Position: Q2 2026 in Review
Norris Perne & French increased its Merck (MRK) stake by 0.28% in Q2 2026, buying an estimated $57.5K and bringing the position to 174,343 shares worth $22.4M. The position accounts for 1.31% of the portfolio, ranked #18.
Norris Perne & French first reported a position in MRK in Q2 2013 and has held it in 53 quarters since. The position peaked at $28.9M in Q3 2024. 1,533 funds tracked by Wall St. Rank hold MRK as of Q2 2026.
- Norris Perne & French held 174,343 shares of Merck worth $22.4M as of Q2 2026.
- Norris Perne & French bought 491 Merck shares in Q2 2026, an estimated $57.5K.
- Merck made up 1.31% of Norris Perne & French's portfolio in Q2 2026, its #18 holding.
- Norris Perne & French first reported a position in Merck in Q2 2013 and has held it in 53 quarters since.
- Norris Perne & French's Merck position peaked at $28.9M in Q3 2024.
- 1,533 funds tracked by Wall St. Rank held Merck as of Q2 2026.
Based on Norris Perne & French's 13F filing for Q2 2026, filed 21 Jul 2026.